ZIOPHARM Oncology Inc. (NASDAQ:ZIOP), a biopharmaceutical company focused on the development and commercialization of new cancer immunotherapies, today announced the presentation of clinical …
Griffin’s healthcare analyst Keith Markey was out pounding the table on ZIOPHARM Oncology Inc. (NASDAQ:ZIOP), reiterating a Buy rating and price target of $21, …
ZIOPHARM Oncology Inc. (NASDAQ:ZIOP), a biopharmaceutical company focused on the development and commercialization of new cancer immuno-therapies, today announced the publication of a …
J.P.
Advanced Micro Devices, Inc. (NASDAQ:AMD) increased 3.
Recently, various executives have taken part in insider selling activity for the stocks of Walt Disney Co (NYSE:DIS), Micron Technology, Inc. (NASDAQ:MU), Palo Alto …
Quick SPDR S&P 500 ETF Trust (NYSE ARCA:SPY) forecast update: Back on November 10th 2014 we predicted a spring 2015 high of 2181 …
Some biopharma business development teams had a sleepless weekend. Four healthcare-related acquisitions were announced in quick succession on Monday morning, totaling about $18 billion …
In a research report issued today, J.P.
